This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jun;16(6):410-411.

doi: 10.1016/S1474-4422(17)30126-6. Epub 2017 Apr 28.

Challenging chronic migraine: targeting the CGRP receptor

Maria Adele Giamberardino¹, Raffaele Costantini²

Affiliations

Affiliations

¹ Headache Center, Department of Medicine and Science of Aging, and Center on Aging Science and Translational Medicine, G D'Annunzio University of Chieti, 66100 Chieti, Italy. Electronic address: mag@unich.it.
² Institute of Surgical Pathology, Department of Medical, Oral and Biotechnological Sciences, G D'Annunzio University of Chieti, 66100 Chieti, Italy.

PMID: 28460891
DOI: 10.1016/S1474-4422(17)30126-6

Comment

Challenging chronic migraine: targeting the CGRP receptor

Maria Adele Giamberardino et al. Lancet Neurol. 2017 Jun.

. 2017 Jun;16(6):410-411.

doi: 10.1016/S1474-4422(17)30126-6. Epub 2017 Apr 28.

Authors

Maria Adele Giamberardino¹, Raffaele Costantini²

Affiliations

¹ Headache Center, Department of Medicine and Science of Aging, and Center on Aging Science and Translational Medicine, G D'Annunzio University of Chieti, 66100 Chieti, Italy. Electronic address: mag@unich.it.
² Institute of Surgical Pathology, Department of Medical, Oral and Biotechnological Sciences, G D'Annunzio University of Chieti, 66100 Chieti, Italy.

PMID: 28460891
DOI: 10.1016/S1474-4422(17)30126-6

No abstract available

PubMed Disclaimer

Comment on

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial.
Tepper S, Ashina M, Reuter U, Brandes JL, Doležil D, Silberstein S, Winner P, Leonardi D, Mikol D, Lenz R. Tepper S, et al. Lancet Neurol. 2017 Jun;16(6):425-434. doi: 10.1016/S1474-4422(17)30083-2. Epub 2017 Apr 28. Lancet Neurol. 2017. PMID: 28460892 Clinical Trial.

Similar articles

Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
Bigal ME, Walter S, Rapoport AM. Bigal ME, et al. Headache. 2013 Sep;53(8):1230-44. doi: 10.1111/head.12179. Epub 2013 Jul 12. Headache. 2013. PMID: 23848260 Review.
Therapeutic antibodies against CGRP or its receptor.
Bigal ME, Walter S, Rapoport AM. Bigal ME, et al. Br J Clin Pharmacol. 2015 Jun;79(6):886-95. doi: 10.1111/bcp.12591. Br J Clin Pharmacol. 2015. PMID: 25614243 Free PMC article. Review.
Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment.
MaassenVanDenBrink A, Terwindt GM, van den Maagdenberg AMJM. MaassenVanDenBrink A, et al. Genome Med. 2018 Feb 22;10(1):10. doi: 10.1186/s13073-018-0524-7. Genome Med. 2018. PMID: 29471874 Free PMC article.
The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
Edvinsson L. Edvinsson L. Headache. 2017 May;57 Suppl 2:47-55. doi: 10.1111/head.13081. Headache. 2017. PMID: 28485848 Review.
Regulation of signal transduction by calcitonin gene-related peptide receptors.
Walker CS, Conner AC, Poyner DR, Hay DL. Walker CS, et al. Trends Pharmacol Sci. 2010 Oct;31(10):476-83. doi: 10.1016/j.tips.2010.06.006. Epub 2010 Jul 13. Trends Pharmacol Sci. 2010. PMID: 20633935 Review.

See all similar articles

Cited by

α7 Nicotinic acetylcholine receptor-mediated anti-inflammatory effect in a chronic migraine rat model via the attenuation of glial cell activation.
Liu Q, Liu C, Jiang L, Li M, Long T, He W, Qin G, Chen L, Zhou J. Liu Q, et al. J Pain Res. 2018 Jun 15;11:1129-1140. doi: 10.2147/JPR.S159146. eCollection 2018. J Pain Res. 2018. PMID: 29942148 Free PMC article.
Acute headache management in emergency department. A narrative review.
Giamberardino MA, Affaitati G, Costantini R, Guglielmetti M, Martelletti P. Giamberardino MA, et al. Intern Emerg Med. 2020 Jan;15(1):109-117. doi: 10.1007/s11739-019-02266-2. Epub 2020 Jan 1. Intern Emerg Med. 2020. PMID: 31893348 Review.
Effects of topical vs injection treatment of cervical myofascial trigger points on headache symptoms in migraine patients: a retrospective analysis.
Affaitati G, Costantini R, Tana C, Lapenna D, Schiavone C, Cipollone F, Giamberardino MA. Affaitati G, et al. J Headache Pain. 2018 Nov 8;19(1):104. doi: 10.1186/s10194-018-0934-3. J Headache Pain. 2018. PMID: 30409108 Free PMC article.
Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab.
Giamberardino MA, Affaitati G, Costantini R, Cipollone F, Martelletti P. Giamberardino MA, et al. J Pain Res. 2017 Dec 8;10:2751-2760. doi: 10.2147/JPR.S128143. eCollection 2017. J Pain Res. 2017. PMID: 29263689 Free PMC article. Review.
Co-occurrence of pain syndromes.
Affaitati G, Costantini R, Tana C, Cipollone F, Giamberardino MA. Affaitati G, et al. J Neural Transm (Vienna). 2020 Apr;127(4):625-646. doi: 10.1007/s00702-019-02107-8. Epub 2019 Nov 29. J Neural Transm (Vienna). 2020. PMID: 31784821 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program